On October 5, 2026, The Goldman Sachs Group, Inc. became subject to the disclosure obligation for ZAI LAB (09688) following an increase in its reportable security interest in listed derivatives positions. This resulted in an acquisition of 60.64 million shares (long position). The transaction was an off-exchange derivative trade and not a direct on-market dealing.
Prior to the acquisition, The Goldman Sachs Group, Inc.'s long position in ZAI LAB was 56.08 million shares, representing 4.93%; following the acquisition, the holding changed to 60.64 million shares, with the long position ratio rising to 5.33%.